The microbiome in spondyloarthritis.

Area of Science:

• Microbiology and immunology
• Gastroenterology
• Rheumatology

Background:

• Inflammatory disorders like ankylosing spondylitis (AS) and spondyloarthritis (SpA) are suspected to be linked to the body's microbial communities.
• The gut microbiota, in particular, is increasingly studied due to advancements in metagenomics.
• Microbiota imbalance, or dysbiosis, is a key area of investigation in SpA.

Purpose of the Study:

• To review evidence linking gut microbiota dysbiosis to spondyloarthritis (SpA).
• To explore the potential causal relationship between gut dysbiosis and SpA development.
• To discuss potential therapeutic strategies targeting the microbiota in SpA.

Main Methods:

• Literature review of existing studies on microbiota and SpA.
• Analysis of evidence supporting dysbiosis in SpA patients.
• Examination of research on the causal role of gut microbiota in disease pathogenesis.

Main Results:

• Evidence suggests a significant association between gut microbiota dysbiosis and SpA.
• Dysbiosis may play a causal role in the development and progression of SpA.
• The gut microbiota presents potential therapeutic targets for SpA management.

Conclusions:

• Gut microbiota dysbiosis is strongly implicated in spondyloarthritis (SpA).
• Further research is needed to fully elucidate the causal mechanisms.
• Targeting the gut microbiota offers promising therapeutic avenues for SpA.